{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T06:43:32Z","timestamp":1694241812123},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Prolonged survival of lesional T cells plays a central role in the pathogenesis of T-cell-mediated dermatoses. We have recently shown that the ubiquitin ligase c-CBL is highly expressed in cutaneous T-cell lymphoma (CTCL) and that its knockdown increases activation-induced cell death, a key pathway for T-cell apoptosis. Here, we extend our work on c-CBL expression in malignant T cells to their nonneoplastic counterparts in benign inflammatory dermatoses. Immunohistochemical staining with anti-c-CBL antibody was performed on lesional biopsies from a total of 65 patients with atopic dermatitis, allergic contact dermatitis, pityriasis rosea, psoriasis vulgaris, lichen planus, mycosis fungoides (MF)\/S\u00e9zary syndrome (SS) as well as on tonsil tissue from 5 individuals and on 5 human CTCL cell lines. Protein levels were measured in situ using multispectral image analysis, a quantitative method that is \u00d75 more sensitive than standard immunohistology for antigen detection. There was a significant (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and progressive increase of mean c-CBL expression across the spectrum of inflammatory dermatoses (2-fold), MF\/SS (3-fold), and lymphoma cell lines (4-fold) as compared with tonsillar T lymphocytes. A subset of MF\/SS cases expressed mean c-CBL levels above the ranges observed in inflammatory dermatoses. Given our prior finding that c-CBL inhibits activation-induced cell death, c-CBL might play a role in the pathogenesis of inflammatory dermatoses and CTCL.<\/jats:p>","DOI":"10.1097\/dad.0000000000000780","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T09:51:44Z","timestamp":1477993904000},"page":"731-737","source":"Crossref","is-referenced-by-count":3,"title":["c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases"],"prefix":"10.1097","volume":"39","author":[{"given":"Katrin A.","family":"Salva","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo J.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI; and"},{"name":"Department of Dermatology, William S. Middleton VA Medical Center, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.coi.2004.09.004","article-title":"Apoptosis in tissue inflammation and allergic disease","volume":"16","author":"Akdis","year":"2004","journal-title":"Curr Opin Immunol."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","article-title":"Death receptors in cutaneous biology and disease","volume":"115","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1471-4906(01)02004-X","article-title":"New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis","volume":"22","author":"Trautman","year":"2001","journal-title":"Trends Immunol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2002.110101.x","article-title":"Activation-induced cell death: a special program able to preserve the homeostasis of the skin?","volume":"11","author":"De Panfilis","year":"2002","journal-title":"Exp Dermatol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri2115","article-title":"Life and death in peripheral T cells","volume":"7","author":"Krammer","year":"2007","journal-title":"Natl Rev Immunol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation-induced cell death in T cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol Rev."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/jid.2009.14","article-title":"Targeting apoptosis defects in cutaneous T-cell lymphoma","volume":"129","author":"Contassot","year":"2009","journal-title":"J Invest Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/sj.jid.5700868","article-title":"Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells","volume":"127","author":"Braun","year":"2007","journal-title":"J Invest Dermatol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archdermatol.2010.376","article-title":"Reduction of Fas\/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma","volume":"147","author":"Wu","year":"2011","journal-title":"Arch Dermatol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-08-4631","article-title":"Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death","volume":"69","author":"Klemke","year":"2009","journal-title":"Cancer Res."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"1327.e1","DOI":"10.1016\/j.jaad.2012.05.035","article-title":"The FAS apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis","volume":"67","author":"Stutz","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/jid.2014.364","article-title":"C-Cbl E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death","volume":"135","author":"Wu","year":"2015","journal-title":"J Invest Dermatol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.immunol.22.012703.104813","article-title":"Ubiquitin ligases and the immune response","volume":"22","author":"Liu","year":"2004","journal-title":"Annu Rev Immunol."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nsmb.2780","article-title":"New insights into ubiquitin E3 ligase mechanism","volume":"21","author":"Berndsen","year":"2014","journal-title":"Nat Struct Mol Biol."},{"key":"R16-20230908","first-page":"907","article-title":"The Cbl interactome and its functions","volume":"6","author":"Schmidt","year":"2005","journal-title":"Mol Cell Biol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","article-title":"Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases","volume":"1833","author":"Mohapatra","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4161\/cc.6.20.4797","article-title":"The ubiquitin E3 ligase Cbl-b in T-cell tolerance and tumor immunity","volume":"6","author":"Loeser","year":"2007","journal-title":"Cell Cycle"},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/eji.200939662","article-title":"E3 ubiquitin ligases in T-cell tolerance","volume":"39","author":"Paolino","year":"2009","journal-title":"Eur J Immunol."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4049\/jimmunol.1202068","article-title":"T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells","volume":"191","author":"Qiao","year":"2013","journal-title":"J Immunol."},{"key":"R21-20230908","first-page":"S169","article-title":"Analysis of protein expression in situ using multi-spectral imaging is superior to conventional immunohistochemistry (IHC): a new paradigm for patient selection for targeted therapy","volume":"133","author":"Salva","year":"2013","journal-title":"J Invest Dermatol Symp Proc."},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00431220","article-title":"A continuous T-cell line from a patient with S\u00e9zary syndrome","volume":"279","author":"Kaltoft","year":"1987","journal-title":"Arch Dermatol Res."},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910490218","article-title":"Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor","volume":"49","author":"Starkebaum","year":"1991","journal-title":"Int J Cancer."},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1523-1747.ep12514693","article-title":"A clonal CD4-positive T-cell line established from the blood of a patient with S\u00e9zary syndrome","volume":"96","author":"Abrams","year":"1991","journal-title":"J Invest Dermatol."},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","article-title":"Human cutaneous T cell lymphoma and leukemia cell line produce and respond to T cell growth factor","volume":"154","author":"Gootenberg","year":"1981","journal-title":"J Exp Med."},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"In Vitro Cell Dev Biol."},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.leukres.2012.04.018","article-title":"Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia","volume":"36","author":"Saito","year":"2012","journal-title":"Leuk Res."},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1002\/cncr.26153","article-title":"An E3 ubiquitin ligase c-Cbl: a new therapeutic target of lung cancer in cell and animal models","volume":"117","author":"Lo","year":"2011","journal-title":"Cancer"},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/cr.2009.74","article-title":"Cbl negatively regulates JNK activation and cell death","volume":"19","author":"Sproul","year":"2009","journal-title":"Cell Res."},{"key":"R30-20230908","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat Genet."},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4161\/cc.9.6.11034","article-title":"Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms","volume":"9","author":"Ogawa","year":"2010","journal-title":"Cell Cycle"},{"key":"R32-20230908","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-01-066076","article-title":"Flt3-dependent transformation by inactivating c-CBL mutations in AML","volume":"110","author":"Sagrin","year":"2007","journal-title":"Blood"},{"key":"R33-20230908","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumor suppressor in myeloid neoplasms","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"key":"R34-20230908","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-010-0920-6","article-title":"Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies","volume":"89","author":"Bacher","year":"2010","journal-title":"Ann Hematol."},{"key":"R35-20230908","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-09-1710","article-title":"The EphB6 receptor cooperates with c-CBL to regulate the behavior of breast cancer cells","volume":"70","author":"Truitt","year":"2010","journal-title":"Cancer Res."},{"key":"R36-20230908","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-\u0138B canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"R37-20230908","doi-asserted-by":"crossref","first-page":"35185","DOI":"10.1074\/jbc.M102219200","article-title":"Src-catalyzed phosphorylation of c-CBL leads to the interdependent ubiquitination of both proteins","volume":"276","author":"Yokouchi","year":"2001","journal-title":"J Biol Chem."},{"key":"R38-20230908","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R39-20230908","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med."},{"key":"R40-20230908","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2796.2009.02083.x","article-title":"Infectious agents and lymphoma development: molecular and clinical aspects","volume":"265","author":"Ferreri","year":"2009","journal-title":"J Intern Med."},{"key":"R41-20230908","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archderm.1984.01650370089016","article-title":"Atopic dermatitis and S\u00e9zary syndrome","volume":"120","author":"Rajka","year":"1984","journal-title":"Arch Dermatol."},{"key":"R42-20230908","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1524-4725.1986.tb02088.x","article-title":"Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis","volume":"12","author":"Abel","year":"1986","journal-title":"J Dermatol Surg Oncol."},{"key":"R43-20230908","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1525-1470.2006.00291.x","article-title":"Hypopigmented mycosis fungoides associated with atopy in two children","volume":"23","author":"Onsun","year":"2006","journal-title":"Pediatr Dermatol."},{"key":"R44-20230908","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000182251","article-title":"Cutaneous T cell lymphoma complicating severe atopic dermatitis","volume":"218","author":"Meyer","year":"2009","journal-title":"Dermatology"},{"key":"R45-20230908","first-page":"1068","article-title":"Folliculotropic mycosis fungoides in a psoriatic patient under methotrexate treatment","volume":"7","author":"Di Lernia","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"R46-20230908","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajd.12182","article-title":"Heavy metal (monoclonal) bands: a link between cutaneous T-cell lymphoma and contact allergy to potassium dichromate, nickel and cobalt?","volume":"56","author":"Tilakaratne","year":"2015","journal-title":"Australas J Dermatol."},{"key":"R47-20230908","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.27740","article-title":"Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series","volume":"119","author":"Jahan-Tigh","year":"2013","journal-title":"Cancer"},{"key":"R48-20230908","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/bjd.14238","article-title":"Unmasking mycosis fungoides\/S\u00e9zary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course","volume":"174","author":"Foo","year":"2016","journal-title":"Br J Dermatol."},{"key":"R49-20230908","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.1999.02655.x","article-title":"Malignant tumours and psoriasis: a follow-up study","volume":"140","author":"Frentz","year":"1999","journal-title":"Br J Dermatol."},{"key":"R50-20230908","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","article-title":"Psoriasis, its treatment, and cancer in a cohort of Finnish patients","volume":"114","author":"Hanuksela-Svahn","year":"2000","journal-title":"J Invest Dermatol."},{"key":"R51-20230908","first-page":"778","article-title":"The risk of malignancy associated with psoriasis","volume":"137","author":"Margolis","year":"2001","journal-title":"Arch Dermatol."},{"key":"R52-20230908","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archderm.139.11.1425","article-title":"Lymphoma rates are low but increased in patients with psoriasis","volume":"139","author":"Gelfand","year":"2003","journal-title":"Arch Dermatol."},{"key":"R53-20230908","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2003.05551.x","article-title":"Cutaneous T-cell lymphoma and atopy: is there an association?","volume":"149","author":"Mehrany","year":"2003","journal-title":"Br J Dermatol."},{"key":"R54-20230908","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","article-title":"The risk of lymphoma in patients with psoriasis","volume":"126","author":"Gelfand","year":"2006","journal-title":"J Invest Dermatol."},{"key":"R55-20230908","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"R56-20230908","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/jid.2009.113","article-title":"Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis","volume":"129","author":"Brauchli","year":"2009","journal-title":"J Invest Dermatol."},{"key":"R57-20230908","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jdv.12165","article-title":"Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies","volume":"27","author":"Pouplard","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R58-20230908","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","article-title":"Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis","volume":"72","author":"Legendre","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"R59-20230908","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamadermatol.2015.4847","article-title":"The risk of cancer in patients with psoriasis: a population-based cohort study in the Health Improvement network","volume":"152","author":"Chiesa Fuxench","year":"2016","journal-title":"JAMA Dermatol."},{"key":"R60-20230908","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/exd.12374","article-title":"Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues","volume":"23","author":"Wu","year":"2014","journal-title":"Exp Dermatol."},{"key":"R61-20230908","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/DAD.0000000000000323","article-title":"Multispectral imaging approach to the diagnosis of a CD20+ cutaneous T-cell lymphoproliferative disorder (CTCLPD): a case report","volume":"37","author":"Salva","year":"2015","journal-title":"Am J Dermatopathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201710000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:06:39Z","timestamp":1694145999000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201710000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000780","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}